RIM
CMD

Ranger Investment Management’s Cantel Medical Corporation CMD Stock Holding History

Ranger Investment Management’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-350,989
Closed -$26.1M – 127
2018
Q4 		$26.1M Sell
350,989
-5,428
-2% -$448K 2.13% 19
2018
Q3 		$32.8M Buy
356,417
+75,428
+27% +$7.18M 2.17% 18
2018
Q2 		$27.6M Buy
280,989
+57,901
+26% +$6.48M 1.93% 21
2018
Q1 		$24.9M Sell
223,088
-40,780
-15% -$4.57M 1.84% 23
2017
Q4 		$27.1M Sell
263,868
-248,755
-49% -$24.8M 1.99% 20
2017
Q3 		$48.3M Sell
512,623
-34,012
-6% -$2.68M 3.62% 3
2017
Q2 		$42.6M Buy
546,635
+280,632
+105% +$21.1M 3.04% 4
2017
Q1 		$21.3M Sell
266,003
-3,207
-1% -$255K 1.55% 35
2016
Q4 		$21.2M Sell
269,210
-7,300
-3% -$567K 1.5% 35
2016
Q3 		$21.6M Sell
276,510
-112,670
-29% -$8.17M 1.55% 29
2016
Q2 		$26.7M Sell
389,180
-17,870
-4% -$1.23M 1.65% 26
2016
Q1 		$29M Sell
407,050
-125,728
-24% -$7.89M 1.78% 22
2015
Q4 		$33.1M Sell
532,778
-29,139
-5% -$1.78M 1.95% 21
2015
Q3 		$31.9M Sell
561,917
-14,102
-2% -$747K 1.8% 24
2015
Q2 		$30.9M Sell
576,019
-14,873
-3% -$723K 1.51% 26
2015
Q1 		$28.1M Buy
590,892
+790
+0.1% +$35K 1.37% 32
2014
Q4 		$25.5M Sell
590,102
-357,220
-38% -$14.6M 1.31% 36
2014
Q3 		$32.6M Sell
947,322
-33,928
-3% -$1.2M 1.72% 25
2014
Q2 		$35.9M Buy
981,250
+253,220
+35% +$8.59M 1.75% 21
2014
Q1 		$24.5M Sell
728,030
-3,695
-0.5% -$122K 1.18% 41
2013
Q4 		$24.8M Sell
731,725
-139,135
-16% -$4.82M 1.17% 44
2013
Q3 		$27.7M Buy
870,860
+21,867
+3% +$582K 1.19% 39
2013
Q2 		$19.2M Buy
+848,993
New +$18.4M 0.93% 54

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Ranger Investment Management's CMD Position: Q1 2019 in Review

Ranger Investment Management sold out of Cantel Medical Corporation (CMD) in Q1 2019, closing a stake of 350,989 shares — an estimated $26.1M sold.

Ranger Investment Management first reported a position in CMD in Q2 2013 and held it in 23 quarters. The position peaked at $48.3M in Q3 2017. 254 funds tracked by Wall St. Rank hold CMD as of Q1 2019.

  • Ranger Investment Management reported no remaining Cantel Medical Corporation position as of Q1 2019 after selling out during the quarter.
  • Ranger Investment Management sold 350,989 Cantel Medical Corporation shares in Q1 2019, an estimated $26.1M.
  • Ranger Investment Management first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 23 quarters.
  • Ranger Investment Management's Cantel Medical Corporation position peaked at $48.3M in Q3 2017.
  • 254 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2019.

Based on Ranger Investment Management's 13F filing for Q1 2019, filed 15 May 2019.